ACTHREL - 55566-0302-1 - (corticorelin ovine triflutate)

Alphabetical Index


Drug Information of ACTHREL

Product NDC: 55566-0302
Proprietary Name: ACTHREL
Non Proprietary Name: corticorelin ovine triflutate
Active Ingredient(s): 100    ug/2mL & nbsp;   corticorelin ovine triflutate
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ACTHREL

Product NDC: 55566-0302
Labeler Name: Ferring Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020162
Marketing Category: NDA
Start Marketing Date: 19960523

Package Information of ACTHREL

Package NDC: 55566-0302-1
Package Description: 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1)

NDC Information of ACTHREL

NDC Code 55566-0302-1
Proprietary Name ACTHREL
Package Description 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1)
Product NDC 55566-0302
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name corticorelin ovine triflutate
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19960523
Marketing Category Name NDA
Labeler Name Ferring Pharmaceuticals Inc.
Substance Name CORTICORELIN OVINE TRIFLUTATE
Strength Number 100
Strength Unit ug/2mL
Pharmaceutical Classes

Complete Information of ACTHREL


General Information